HKB's Mouse Systemic Sclerosis Models provide pharmaceutical researchers with robust platforms for investigating skin fibrosis and developing anti-fibrotic interventions. Our validated rodent models replicate key features of SSc including progressive skin thickening, collagen deposition, and vascular dysfunction.